Amgen on Wednesday said it has started two critical late-stage trials for its experimental weight loss injection MariTide, another step in its bid to enter the booming obesity drug market.
March 6, 2025 - 15:50
By Pharos Investment Advisors Comments are Off
Amgen on Wednesday said it has started two critical late-stage trials for its experimental weight loss injection MariTide, another step in its bid to enter the booming obesity drug market.
November 13, 2024 - 15:39
By Pharos Investment Advisors Comments are Off
Shares of Amgen fell more than 7% Tuesday as analysts chewed over bone density loss data from an early-stage trial on its experimental weight loss injection, MariTide.
Regulated by Hellenic Capital Market Commission
with Registration Number 5/700/10.12.2014
Copyright 2023©. All Rights Reserved